Eriko Hiruta
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of naldemedine for opioid-induced constipation in older patients with cancer: a retrospective study.
Journal: European journal of gastroenterology & hepatology
Published: March 13, 2024
Efficacy and Safety of Naldemedine Administration for Opioid-Induced Constipation in Cancer Patients with Poor Performance Status.
Journal: Journal of palliative medicine
Published: March 27, 2023
A Retrospective Study of the Efficacy and Safety of Naldemedine for Treatment of Opioid-Induced Constipation in Patients with Hepatobiliary Pancreatic Cancer.
Journal: Medicina (Kaunas, Lithuania)
Published: December 07, 2022
Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis.
Journal: Annals of palliative medicine
Published: October 02, 2022
Efficacy and Safety of Naldemedine for Patients with Cancer with Opioid-Induced Constipation in Clinical Practice: A Real-World Retrospective Study.
Journal: Journal of clinical medicine
Published: March 15, 2022
Real-World Patient Characteristics and Treatment Patterns of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Cancer: A Multicenter Retrospective Chart Review Study.
Journal: Medicina (Kaunas, Lithuania)
Published: September 03, 2021
Effects of Sex and Seasonal Climatic Changes on the Risk of Incidence of Anti-EGFR Therapy-Induced Rash in Cancer Patients: A Retrospective Study.
Journal: Medicina (Kaunas, Lithuania)
Published: June 21, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026